ArticleScientific reports2020

Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis.

Lucy Kappes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.